Claret Asset Management Corp Bristol Myers Squibb CO Transaction History
Claret Asset Management Corp
- $693 Million
- Q1 2025
A detailed history of Claret Asset Management Corp transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Claret Asset Management Corp holds 172,985 shares of BMY stock, worth $8.32 Million. This represents 1.52% of its overall portfolio holdings.
Number of Shares
172,985
Previous 174,623
0.94%
Holding current value
$8.32 Million
Previous $9.88 Million
6.81%
% of portfolio
1.52%
Previous 1.56%
Shares
27 transactions
Others Institutions Holding BMY
# of Institutions
2,810Shares Held
1.59BCall Options Held
25.9MPut Options Held
23.9M-
Vanguard Group Inc Valley Forge, PA191MShares$9.2 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.63 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$5.2 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.56 Billion0.24% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$3.2 Billion0.83% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $102B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...